Brycen Gray and Ben Price COVID–19 Neurological Impact Act

12/30/2022, 7:33 AM

Brycen Gray and Ben Price COVID-19 Neurological Impact Act

This bill authorizes grants and requires other activities to address neurological and psychiatric illnesses associated with COVID-19 infection.

Specifically, the National Science Foundation may award competitive grants for multidisciplinary research on such illnesses.

In addition, the White House Office of Science and Technology Policy must establish a temporary interagency working group to coordinate relevant federal programs, data collection, and other activities focused on neurological and psychiatric illnesses associated with COVID-19 infection. The working group must also engage with researchers and nonfederal stakeholders to ensure the sharing and dissemination of relevant research, information, and best practices pertaining to those illnesses. The working group terminates after five years.

Bill 117 HR 5772, also known as the Brycen Gray and Ben Price COVID-19 Neurological Impact Act, is a piece of legislation introduced in the US Congress. The purpose of this bill is to address the neurological impact of COVID-19 on individuals who have contracted the virus.

The bill is named after Brycen Gray and Ben Price, two individuals who have experienced neurological symptoms as a result of COVID-19. The legislation aims to provide funding for research into the neurological effects of the virus, as well as support for individuals who are suffering from these symptoms.

Specifically, the bill calls for the establishment of a task force to study the neurological impact of COVID-19 and develop recommendations for treatment and support for affected individuals. It also includes provisions for funding research into the long-term effects of the virus on the brain and nervous system. Overall, the Brycen Gray and Ben Price COVID-19 Neurological Impact Act seeks to address a critical aspect of the ongoing COVID-19 pandemic and provide support for individuals who are experiencing neurological symptoms as a result of the virus.
Congress
117

Number
HR - 5772

Introduced on
2021-10-28

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

10/28/2021

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Brycen Gray and Ben Price COVID-19 Neurological Impact Act

This bill authorizes grants and requires other activities to address neurological and psychiatric illnesses associated with COVID-19 infection.

Specifically, the National Science Foundation may award competitive grants for multidisciplinary research on such illnesses.

In addition, the White House Office of Science and Technology Policy must establish a temporary interagency working group to coordinate relevant federal programs, data collection, and other activities focused on neurological and psychiatric illnesses associated with COVID-19 infection. The working group must also engage with researchers and nonfederal stakeholders to ensure the sharing and dissemination of relevant research, information, and best practices pertaining to those illnesses. The working group terminates after five years.

Bill 117 HR 5772, also known as the Brycen Gray and Ben Price COVID-19 Neurological Impact Act, is a piece of legislation introduced in the US Congress. The purpose of this bill is to address the neurological impact of COVID-19 on individuals who have contracted the virus.

The bill is named after Brycen Gray and Ben Price, two individuals who have experienced neurological symptoms as a result of COVID-19. The legislation aims to provide funding for research into the neurological effects of the virus, as well as support for individuals who are suffering from these symptoms.

Specifically, the bill calls for the establishment of a task force to study the neurological impact of COVID-19 and develop recommendations for treatment and support for affected individuals. It also includes provisions for funding research into the long-term effects of the virus on the brain and nervous system. Overall, the Brycen Gray and Ben Price COVID-19 Neurological Impact Act seeks to address a critical aspect of the ongoing COVID-19 pandemic and provide support for individuals who are experiencing neurological symptoms as a result of the virus.
Alternative Names
Official Title as IntroducedTo authorize the Director of the National Science Foundation to award grants to support research on neurological and psychiatric illnesses associated with COVID-19 infection, and for other purposes.

Policy Areas
Health

Potential Impact
Cardiovascular and respiratory health
Child health
Emergency medical services and trauma care
Executive Office of the President
Executive agency funding and structure
Health information and medical records
Infectious and parasitic diseases
Medical research
Medical tests and diagnostic methods
Mental health
Neurological disorders
Research administration and funding

Comments

Recent Activity

Latest Summary3/11/2022

Brycen Gray and Ben Price COVID-19 Neurological Impact Act

This bill authorizes grants and requires other activities to address neurological and psychiatric illnesses associated with COVID-19 infection.

Specifically...


Latest Action10/29/2021
Referred to the Subcommittee on Health.